Sulfisoxazole (cas 127-69-5)
-
Add time:09/10/2019 Source:sciencedirect.com
Sulfisoxazole is a sulfonamide antibacterial agent that is rapidly absorbed and short-acting. Sulfisoxazole is used for the treatment of acute urinary tract infections. Because sulfisoxazole does not penetrate cells and pass barriers as well as most sulfonamides, it may not always be effective against systemic infections that are sensitive to other sulfonamides. It is employed for the treatment of acute otitis media or in the prophylaxis of chronic otitis. Hypersensitivity reactions and gastrointestinal effects are the adverse reactions most commonly encountered with sulfisoxazole and most other sulfonamides.
We also recommend Trading Suppliers and Manufacturers of Sulfisoxazole (cas 127-69-5). Pls Click Website Link as below: cas 127-69-5 suppliers
Prev:Short communicationSimultaneous determination of N1-acetyl Sulfisoxazole (cas 127-69-5) and its metabolites, and relative bioavailability compare to Sulfisoxazole (cas 127-69-5) in rats
Next:Polymer-free electrospun nanofibers from sulfobutyl ether7-beta-cyclodextrin (SBE7-β-CD) inclusion complex with Sulfisoxazole (cas 127-69-5): Fast-dissolving and enhanced water-solubility of Sulfisoxazole (cas 127-69-5)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Sulfisoxazole (cas 127-69-5)/cyclodextrin inclusion complex incorporated in electrospun hydroxypropyl cellulose nanofibers as drug delivery system09/29/2019
- Synthesis, crystallographic studies, high resolution mass spectrometric analyses and antibacterial assays of silver(I) complexes with Sulfisoxazole (cas 127-69-5) and sulfadimethoxine09/28/2019
- Enhanced degradation performance of Sulfisoxazole (cas 127-69-5) using peroxymonosulfate activated by copper-cobalt oxides in aqueous solution: Kinetic study and products identification10/01/2019
- Electro-catalytic degradation of Sulfisoxazole (cas 127-69-5) by using graphene anode09/27/2019
- Quantitative determination of Sulfisoxazole (cas 127-69-5) and its three N-acetylated metabolites using HPLC–MS/MS, and the saturable pharmacokinetics of Sulfisoxazole (cas 127-69-5) in mice09/26/2019
- Insight into the mechanisms for hexavalent chromium reduction and Sulfisoxazole (cas 127-69-5) degradation catalyzed by graphitic carbon nitride: The Yin and Yang in the photo-assisted processes09/25/2019
- Polymer-free electrospun nanofibers from sulfobutyl ether7-beta-cyclodextrin (SBE7-β-CD) inclusion complex with Sulfisoxazole (cas 127-69-5): Fast-dissolving and enhanced water-solubility of Sulfisoxazole (cas 127-69-5)09/24/2019
- Short communicationSimultaneous determination of N1-acetyl Sulfisoxazole (cas 127-69-5) and its metabolites, and relative bioavailability compare to Sulfisoxazole (cas 127-69-5) in rats09/09/2019